Blood Vessel Maturation in Retinoblastoma Tumors: Spatial Distribution of Neovessels and Mature Vessels and Its Impact on Ocular Treatment
- 1 March 2009
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 50 (3), 1020-1024
- https://doi.org/10.1167/iovs.08-2654
Abstract
Purpose. The purposes of this study were to evaluate the spatial distribution of neovessels versus mature vessels in both human retinoblastoma (RB) and LHBETATAG tumors, assess similarities and differences between the animal model and the human RB specimens, and determine whether vessel maturation is associated with risk factors for metastasis.This publication has 10 references indexed in Scilit:
- Conservative Treatments of Intraocular RetinoblastomaOphthalmology, 2008
- Outcome of Patients with Retinoblastoma and Postlaminar Optic Nerve InvasionOphthalmology, 2007
- Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusionBlood, 2007
- Retinoblastoma Tumor Vessel Maturation Impacts Efficacy of Vessel Targeting in the LHBETATAGMouse ModelPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2007
- Anecortave Acetate as Single and Adjuvant Therapy in the Treatment of Retinal Tumors of LHBETATAGMicePublished by Association for Research in Vision and Ophthalmology (ARVO) ,2006
- Combined Immunologic and Anti-Angiogenic Therapy Reduces Hepatic Micrometastases in a Murine Ocular Melanoma ModelCurrent Eye Research, 2006
- Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?British Journal of Ophthalmology, 2004
- Tumorigenesis and the angiogenic switchNature Reviews Cancer, 2003
- Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitorsJCI Insight, 2003
- Promises and pitfalls of anti-angiogenic therapy in clinical trialsTrends in Molecular Medicine, 2003